# Biopolar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biopolar

- Industry: Pharmaceuticals
- Headquarters: Nantong, China
- Latest round: Series A (Oct 14, 2021)
- Investors on record: 2

## About

Established in 2018 and based in Nantong, China, Biopolar is a pharmaceutical technology company that focuses on the development of small molecule drugs for the treatment of hematological tumors and immune diseases. The company has a research and development team of nearly 40 employees.

The company engages in the development of small molecule drugs for the treatment of hematological tumors and immune diseases. Its main products include BPHY-01, BPHY-02 and BPHY-03 etc. It also has a preclinical drug development platform.

## Funding rounds

- Series A, Oct 14, 2021 — Fuho Capital, Timesbole Venture Capital

## Investors

- Fuho Capital (https://capitalatlas.ai/funds/fuho-capital) — Series A
- Timesbole Venture Capital (https://capitalatlas.ai/funds/timesbole-venture-capital) — Series A